GPW
BMY icon

Genesis Private Wealth’s Bristol-Myers Squibb BMY Stock Holding History

Genesis Private Wealth’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,641
Closed -$283K – 156
2025
Q1 		$283K Sell
4,641
-630
-12% -$36.7K 0.15% 88
2024
Q4 		$298K Buy
+5,271
New +$295K 0.16% 77

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Genesis Private Wealth's BMY Position: Q2 2025 in Review

Genesis Private Wealth sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,641 shares — an estimated $283K sold.

Genesis Private Wealth first reported a position in BMY in Q4 2024 and held it in 2 quarters. The position peaked at $298K in Q4 2024. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Genesis Private Wealth reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Genesis Private Wealth sold 4,641 Bristol-Myers Squibb shares in Q2 2025, an estimated $283K.
  • Genesis Private Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 2 quarters.
  • Genesis Private Wealth's Bristol-Myers Squibb position peaked at $298K in Q4 2024.
  • 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Genesis Private Wealth's 13F filing for Q2 2025, filed 17 Jul 2025.